IHH Healthcare said on Tuesday its unit has filed a petition in a Tokyo court to revise damages sought from Japan's Daiichi ...

Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the ...

The lawsuit, first announced on Nov 14, 2023, arose from alleged obstruction by the Japanese drug maker against NTK’s efforts ...

IHH Healthcare's indirect subsidiary, Northern TK Venture Pte Ltd, has significantly increased its damages claim against ...

Merck MRK and Japan’s Daiichi Sankyo announced the dosing of the first patient in the phase III IDeate-Esophageal01 study evaluating their B7-H3 directed DXd antibody-drug conjugate (ADC), ifinatamab ...

Malaysia's IHH Healthcare is seeking JPY 200 billion (Rs 11,800 crore) in damages from Japan's Daiichi Sankyo for blocking ...

IHH Healthcare's subsidiary NTK raises damages claim against Daiichi Sankyo to Rs 11,800 crore for obstructing its Fortis ...

The lawsuit pertains to damages arising from the alleged obstruction by Daiichi of NTK’s efforts to acquire shares in Fortis ...

Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over ...

The revised claim stems from NTK’s allegations that Daiichi Sankyo obstructed its 2018 open offer to acquire shares in ...

IHH Healthcare said on Tuesday its unit has filed a petition in a Tokyo court to revise damages sought from Japan's Daiichi ...